ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care Diagnostics (POCD) Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Othe-2Z478
Home | Market Reports | Health| Medical Facilities & Services
Point of Care Diagnostics Market
BUY CHAPTERS

Global Point of Care Diagnostics (POCD) Market Research Report 2024

Code: QYRE-Othe-2Z478
Report
January 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer HealthCare
Beckman Coulter
Nipro Diagnostics
Bio Rad Laboratories
Nova Biomedical
Biomerieux
Quidel
Helena Laboratories
Orasure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Instrumentation Laboratory
Alere Inc
Qiagen NV

Point of Care Diagnostics (POCD) Market Size

The global Point of Care Diagnostics (POCD) market was valued at US$ 25670 million in 2023 and is anticipated to reach US$ 34550 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Point of Care Diagnostics (POCD) Market

Point of Care Diagnostics (POCD) Market

Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point of Care Diagnostics (POCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Diagnostics (POCD).

Report Scope

The Point of Care Diagnostics (POCD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point of Care Diagnostics (POCD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Diagnostics (POCD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Point of Care Diagnostics (POCD) Market Report

Report Metric Details
Report Name Point of Care Diagnostics (POCD) Market
Accounted market size in 2023 US$ 25670 million
Forecasted market size in 2030 US$ 34550 million
CAGR 4.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Tumor Markers Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Others
Segment by Application
  • Clinics
  • Hospitals
  • Assisted Living Healthcare Facilities
  • Laboratory
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech, Instrumentation Laboratory, Sekisui Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Point of Care Diagnostics (POCD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Point of Care Diagnostics (POCD) Market growing?

Ans: The Point of Care Diagnostics (POCD) Market witnessing a CAGR of 4.4% during the forecast period 2024-2030.

What is the Point of Care Diagnostics (POCD) Market size in 2030?

Ans: The Point of Care Diagnostics (POCD) Market size in 2030 will be US$ 34550 million.

Who are the main players in the Point of Care Diagnostics (POCD) Market report?

Ans: The main players in the Point of Care Diagnostics (POCD) Market are Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech, Instrumentation Laboratory, Sekisui Diagnostics

What are the Application segmentation covered in the Point of Care Diagnostics (POCD) Market report?

Ans: The Applications covered in the Point of Care Diagnostics (POCD) Market report are Clinics, Hospitals, Assisted Living Healthcare Facilities, Laboratory

What are the Type segmentation covered in the Point of Care Diagnostics (POCD) Market report?

Ans: The Types covered in the Point of Care Diagnostics (POCD) Market report are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2019-2030)
2.2 Point of Care Diagnostics (POCD) Growth Trends by Region
2.2.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point of Care Diagnostics (POCD) Historic Market Size by Region (2019-2024)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2025-2030)
2.3 Point of Care Diagnostics (POCD) Market Dynamics
2.3.1 Point of Care Diagnostics (POCD) Industry Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2019-2024)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2023
3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2019-2024)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2025-2030)
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2019-2024)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2019-2030)
6.2 North America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2019-2030)
7.2 Europe Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2019-2030)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2019-2030)
9.2 Latin America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2019-2030)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Detail
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Detail
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Detail
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Detail
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Detail
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Detail
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Detail
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Detail
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.18.5 Abaxis Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
11.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.19.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Detail
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Detail
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Detail
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024)
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer HealthCare
Beckman Coulter
Nipro Diagnostics
Bio Rad Laboratories
Nova Biomedical
Biomerieux
Quidel
Helena Laboratories
Orasure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Instrumentation Laboratory
Alere Inc
Qiagen NV
List of Tables
    Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Blood Glucose Testing
    Table 3. Key Players of Infectious Diseases Testing
    Table 4. Key Players of Cardiac Markers Testing
    Table 5. Key Players of Coagulation Testing
    Table 6. Key Players of Pregnancy and Fertility Testing
    Table 7. Key Players of Blood Gas/Electrolytes Testing
    Table 8. Key Players of Tumor Markers Testing
    Table 9. Key Players of Urinalysis Testing
    Table 10. Key Players of Cholesterol Testing
    Table 11. Key Players of Others
    Table 12. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 13. Global Point of Care Diagnostics (POCD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 14. Global Point of Care Diagnostics (POCD) Market Size by Region (2019-2024) & (US$ Million)
    Table 15. Global Point of Care Diagnostics (POCD) Market Share by Region (2019-2024)
    Table 16. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 17. Global Point of Care Diagnostics (POCD) Market Share by Region (2025-2030)
    Table 18. Point of Care Diagnostics (POCD) Market Trends
    Table 19. Point of Care Diagnostics (POCD) Market Drivers
    Table 20. Point of Care Diagnostics (POCD) Market Challenges
    Table 21. Point of Care Diagnostics (POCD) Market Restraints
    Table 22. Global Point of Care Diagnostics (POCD) Revenue by Players (2019-2024) & (US$ Million)
    Table 23. Global Point of Care Diagnostics (POCD) Market Share by Players (2019-2024)
    Table 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2023)
    Table 25. Ranking of Global Top Point of Care Diagnostics (POCD) Companies by Revenue (US$ Million) in 2023
    Table 26. Global 5 Largest Players Market Share by Point of Care Diagnostics (POCD) Revenue (CR5 and HHI) & (2019-2024)
    Table 27. Key Players Headquarters and Area Served
    Table 28. Key Players Point of Care Diagnostics (POCD) Product Solution and Service
    Table 29. Date of Enter into Point of Care Diagnostics (POCD) Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Point of Care Diagnostics (POCD) Market Size by Type (2019-2024) & (US$ Million)
    Table 32. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2019-2024)
    Table 33. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 34. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2025-2030)
    Table 35. Global Point of Care Diagnostics (POCD) Market Size by Application (2019-2024) & (US$ Million)
    Table 36. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2019-2024)
    Table 37. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 38. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2025-2030)
    Table 39. North America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Point of Care Diagnostics (POCD) Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Asia-Pacific Point of Care Diagnostics (POCD) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2019-2024) & (US$ Million)
    Table 47. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2025-2030) & (US$ Million)
    Table 48. Latin America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2025-2030) & (US$ Million)
    Table 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 52. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2019-2024) & (US$ Million)
    Table 53. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2025-2030) & (US$ Million)
    Table 54. Alere Company Detail
    Table 55. Alere Business Overview
    Table 56. Alere Point of Care Diagnostics (POCD) Product
    Table 57. Alere Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 58. Alere Recent Development
    Table 59. Roche Company Detail
    Table 60. Roche Business Overview
    Table 61. Roche Point of Care Diagnostics (POCD) Product
    Table 62. Roche Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 63. Roche Recent Development
    Table 64. Abbott Laboratories Company Detail
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Point of Care Diagnostics (POCD) Product
    Table 67. Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 68. Abbott Laboratories Recent Development
    Table 69. Johnson & Johnson Company Detail
    Table 70. Johnson & Johnson Business Overview
    Table 71. Johnson & Johnson Point of Care Diagnostics (POCD) Product
    Table 72. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 73. Johnson & Johnson Recent Development
    Table 74. Siemens Healthcare Company Detail
    Table 75. Siemens Healthcare Business Overview
    Table 76. Siemens Healthcare Point of Care Diagnostics (POCD) Product
    Table 77. Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 78. Siemens Healthcare Recent Development
    Table 79. Danaher Company Detail
    Table 80. Danaher Business Overview
    Table 81. Danaher Point of Care Diagnostics (POCD) Product
    Table 82. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 83. Danaher Recent Development
    Table 84. QIAGEN Company Detail
    Table 85. QIAGEN Business Overview
    Table 86. QIAGEN Point of Care Diagnostics (POCD) Product
    Table 87. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 88. QIAGEN Recent Development
    Table 89. Bayer Healthcare Company Detail
    Table 90. Bayer Healthcare Business Overview
    Table 91. Bayer Healthcare Point of Care Diagnostics (POCD) Product
    Table 92. Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 93. Bayer Healthcare Recent Development
    Table 94. Beckman Coulter Company Detail
    Table 95. Beckman Coulter Business Overview
    Table 96. Beckman Coulter Point of Care Diagnostics (POCD) Product
    Table 97. Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 98. Beckman Coulter Recent Development
    Table 99. Nipro Diagnostics Company Detail
    Table 100. Nipro Diagnostics Business Overview
    Table 101. Nipro Diagnostics Point of Care Diagnostics (POCD) Product
    Table 102. Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 103. Nipro Diagnostics Recent Development
    Table 104. Bio-Rad Laboratories Company Detail
    Table 105. Bio-Rad Laboratories Business Overview
    Table 106. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product
    Table 107. Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 108. Bio-Rad Laboratories Recent Development
    Table 109. Nova Biomedical Company Detail
    Table 110. Nova Biomedical Business Overview
    Table 111. Nova Biomedical Point of Care Diagnostics (POCD) Product
    Table 112. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 113. Nova Biomedical Recent Development
    Table 114. BioMerieux Company Detail
    Table 115. BioMerieux Business Overview
    Table 116. BioMerieux Point of Care Diagnostics (POCD) Product
    Table 117. BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 118. BioMerieux Recent Development
    Table 119. Quidel Company Detail
    Table 120. Quidel Business Overview
    Table 121. Quidel Point of Care Diagnostics (POCD) Product
    Table 122. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 123. Quidel Recent Development
    Table 124. Helena Laboratories Company Detail
    Table 125. Helena Laboratories Business Overview
    Table 126. Helena Laboratories Point of Care Diagnostics (POCD) Product
    Table 127. Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 128. Helena Laboratories Recent Development
    Table 129. OraSure Technologies Company Detail
    Table 130. OraSure Technologies Business Overview
    Table 131. OraSure Technologies Point of Care Diagnostics (POCD) Product
    Table 132. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 133. OraSure Technologies Recent Development
    Table 134. Accriva Company Detail
    Table 135. Accriva Business Overview
    Table 136. Accriva Point of Care Diagnostics (POCD) Product
    Table 137. Accriva Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 138. Accriva Recent Development
    Table 139. Abaxis Company Detail
    Table 140. Abaxis Business Overview
    Table 141. Abaxis Point of Care Diagnostics (POCD) Product
    Table 142. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 143. Abaxis Recent Development
    Table 144. Chembio Diagnostics Company Detail
    Table 145. Chembio Diagnostics Business Overview
    Table 146. Chembio Diagnostics Point of Care Diagnostics (POCD) Product
    Table 147. Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 148. Chembio Diagnostics Recent Development
    Table 149. Trinity Biotech Company Detail
    Table 150. Trinity Biotech Business Overview
    Table 151. Trinity Biotech Point of Care Diagnostics (POCD) Product
    Table 152. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 153. Trinity Biotech Recent Development
    Table 154. Instrumentation Laboratory Company Detail
    Table 155. Instrumentation Laboratory Business Overview
    Table 156. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product
    Table 157. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 158. Instrumentation Laboratory Recent Development
    Table 159. Sekisui Diagnostics Company Detail
    Table 160. Sekisui Diagnostics Business Overview
    Table 161. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product
    Table 162. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2019-2024) & (US$ Million)
    Table 163. Sekisui Diagnostics Recent Development
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point of Care Diagnostics (POCD) Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Point of Care Diagnostics (POCD) Market Share by Type: 2023 VS 2030
    Figure 3. Blood Glucose Testing Features
    Figure 4. Infectious Diseases Testing Features
    Figure 5. Cardiac Markers Testing Features
    Figure 6. Coagulation Testing Features
    Figure 7. Pregnancy and Fertility Testing Features
    Figure 8. Blood Gas/Electrolytes Testing Features
    Figure 9. Tumor Markers Testing Features
    Figure 10. Urinalysis Testing Features
    Figure 11. Cholesterol Testing Features
    Figure 12. Others Features
    Figure 13. Global Point of Care Diagnostics (POCD) Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 14. Global Point of Care Diagnostics (POCD) Market Share by Application: 2023 VS 2030
    Figure 15. Clinics Case Studies
    Figure 16. Hospitals Case Studies
    Figure 17. Assisted Living Healthcare Facilities Case Studies
    Figure 18. Laboratory Case Studies
    Figure 19. Point of Care Diagnostics (POCD) Report Years Considered
    Figure 20. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 21. Global Point of Care Diagnostics (POCD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Region: 2023 VS 2030
    Figure 23. Global Point of Care Diagnostics (POCD) Market Share by Players in 2023
    Figure 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2023)
    Figure 25. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2023
    Figure 26. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. North America Point of Care Diagnostics (POCD) Market Share by Country (2019-2030)
    Figure 28. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Europe Point of Care Diagnostics (POCD) Market Share by Country (2019-2030)
    Figure 32. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Region (2019-2030)
    Figure 40. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Latin America Point of Care Diagnostics (POCD) Market Share by Country (2019-2030)
    Figure 48. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Country (2019-2030)
    Figure 52. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Alere Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 55. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 56. Abbott Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 58. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 59. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 60. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 61. Bayer Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 62. Beckman Coulter Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 63. Nipro Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 65. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 66. BioMerieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 67. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 68. Helena Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 69. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 70. Accriva Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 71. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 72. Chembio Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 73. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 74. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 75. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Polymerase Chain Reaction for Point of Care Diagnostics Market
Rapid Point of Care PoC Diagnostics Market
Infectious Disease Point of Care Diagnostics Market
Point of Care Infectious Disease Diagnostics Testing Market
Point of care Infectious Disease Diagnostics Market
Cardiology Point of Care Diagnostics Market
Cartridge Based Point of Care Diagnostics System Market
Point of Care Coagulation Testing Market
Point of Care Testing for Infectious Disease Market
Point of Care Testing Market
DNA Testing Diagnostics Market
Mycoplasma Diagnostics Market
Veterinary Point of Care Diagnostics Market
 
 
 
 
 
 
 

RELATED REPORTS

Global ECG And EEG Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29U9219
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Deformity Spinal System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20S6127
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Mammography Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G9187
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global E-Clinical Solution Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Othe-3E434
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions